Company Overview and News
The cryptocurrency market has finally sprung back to life after being plagued by low trade volumes for successive weeks. On Jul 17, Bitcoin — the world’s largest cryptocurrency —surged to its highest levels since the first week of June.
MU AMD INTC
Opinion: Most investors are baking in big gains from chips and big tech companies while watching the forecasts
LRCX FB MS.PRE MS.PRF MS.PRG NFLX AMD GOOG NVDA MS.PRA MS.PRI GOOGL MS.PRK MU TWTR AAPL MS INTC
The US economy continues to strengthen with lower jobless claims and stable unemployment numbers, and trade war fears seem to be abated (at least in the near term). We are also seeing rising retail sales. It should be no surprise that the US markets are holding their own albeit with more volatility than we have seen in several years.
Semiconductor earnings seen growing 38%, but effects of China tariffs in forecasts are where the big uncertainty lies
MRVL XLNX LRCX SLAB HXSCF BC94 CRUS SMSN AMD NVDA MPWR SWKS TER MU AMAT AVGO ADI MKSI BRCM INTC QCOM SMSD HXSCL
Cadence Design Systems Inc. (CDNS - Free Report) is set to report second-quarter 2018 results on Jul 23. Notably, the company has surpassed the Zacks Consensus Estimate in three of the trailing four quarters while coming in line in the remaining one, recording an average positive surprise of 2.81%.
SWKS ASX MSFT AMD CDNS
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Advanced Micro Devices (AMD - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of AMD and the rest of the Computer and Technology group's stocks.
Advanced Micro Devices (NASDAQ:AMD) has been on fire since its last earnings report in late April. While AMD stock wasn’t trading at its absolute lows when it reported, it was pretty close. Anyway, the quarter helped propel shares from roughly $10 to more than $16 currently.
AMD NFLX NVDA INTC
U.S. stocks are mixed early Friday, treading water in the wake of several consequential technical breakouts. Consider that the S&P 500 has extended its break atop major resistance — resolving a double bottom, defined by the April and May lows — while the Nasdaq Composite has concurrently extended its rally atop key trendline resistance.
XLNX TXN WYNN AMD TRYIF NVDA MCHP ON NOC MU BOE AMAT 3402 ADI AVGO TRYIY BRCM QCOM BA INTC
The S&P 500 is an index containing the largest stocks in the country. Investors use it to gauge how stocks are doing overall, as it serves as a snapshot for the U.S. equities market. Generally speaking, the index is also used as a benchmark, as everyone from retail investors to hedge fund managers compare their performance to it.
AMD NYTAB NVDA BRK.A JPM GM.WS.A GM.WS.B GM.WS.C GM INTC GM.WSB DAL MMM
Intel (NASDAQ:INTC) has been a top chip maker since forever, but there could be trouble looming for Intel stock in the form of the Cloud Czars. It is no longer news that the five of them, Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL), Microsoft (NASDAQ:MSFT) and Facebook (NASDAQ:FB), are all in the chip business.
IBM FB AMZN GOOGL AAPL AMD MSFT NVDA QCOM INTC TSM
2017-09-28 - Asif
We are a global semiconductor company with facilities around the world. Within the global semiconductor industry, we offer primarily: x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics processors; and server and embedded processors, semi-custom System-on-Chip (SoC) products and technology for game consoles. We also license portions of our intellectual property portfolio. In this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries (collectively, “us,” “our” or “AMD”), including a discussion of our results of operations for the quarter and six months ended July 1, 2017 compared to the quarter and six months ended June 25, 2016 , an analysis of changes in our financial condition and a discussion of our contractual obligations. We believe our fin...
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to AMD / Advanced Micro Devices, Inc. on message board site Silicon Investor.
as of ET